210 related articles for article (PubMed ID: 9818931)
1. D2 receptor binding in dopa-responsive dystonia.
Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
[TBL] [Abstract][Full Text] [Related]
2. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
3. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
[TBL] [Abstract][Full Text] [Related]
4. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
5. Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
Kishore A; Nygaard TG; de la Fuente-Fernandez R; Naini AB; Schulzer M; Mak E; Ruth TJ; Calne DB; Snow BJ; Stoessl AJ
Neurology; 1998 Apr; 50(4):1028-32. PubMed ID: 9566390
[TBL] [Abstract][Full Text] [Related]
6. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
7. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Turjanski N; Bhatia K; Burn DJ; Sawle GV; Marsden CD; Brooks DJ
Neurology; 1993 Aug; 43(8):1563-8. PubMed ID: 8351012
[TBL] [Abstract][Full Text] [Related]
8. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
Rinne JO; Iivanainen M; Metsähonkala L; Vainionpää L; Pääkkönen L; Någren K; Helenius H
J Neural Transm (Vienna); 2004 Jan; 111(1):59-67. PubMed ID: 14714216
[TBL] [Abstract][Full Text] [Related]
9. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
[TBL] [Abstract][Full Text] [Related]
10. Dopa-responsive dystonia: [18F]dopa positron emission tomography.
Sawle GV; Leenders KL; Brooks DJ; Harwood G; Lees AJ; Frackowiak RS; Marsden CD
Ann Neurol; 1991 Jul; 30(1):24-30. PubMed ID: 1681782
[TBL] [Abstract][Full Text] [Related]
11. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.
Antonini A; Leenders KL; Reist H; Thomann R; Beer HF; Locher J
Arch Neurol; 1993 May; 50(5):474-80. PubMed ID: 8489403
[TBL] [Abstract][Full Text] [Related]
12. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
Antonini A; Leenders KL
Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
[TBL] [Abstract][Full Text] [Related]
14. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
[TBL] [Abstract][Full Text] [Related]
16. The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.
Farkas S; Nagy K; Jia Z; Harkany T; Palkovits M; Donohou SR; Pike VW; Halldin C; Máthé D; Csiba L; Gulyás B
Brain Res Bull; 2012 Apr; 87(6):504-10. PubMed ID: 22421165
[TBL] [Abstract][Full Text] [Related]
17. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
[TBL] [Abstract][Full Text] [Related]
20. Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys.
Ohnishi T; Hayashi T; Okabe S; Nonaka I; Matsuda H; Iida H; Imabayashi E; Watabe H; Miyake Y; Ogawa M; Teramoto N; Ohta Y; Ejima N; Sawada T; Ugawa Y
Biol Psychiatry; 2004 Mar; 55(5):484-9. PubMed ID: 15023576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]